Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 1, 2006, Pages 17-21

  Braga, Eduardo Lorens ^a,b   Lyra, André Castro ^a,b   Ney Oliveira, Fabrizio ^a   Nascimento, Lourianne ^a   Silva, Adriano ^a   Brites, Carlos ^a   Marbak, Rosicreuza ^a,b   Lyra, Luiz Guilherme Costa ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Monte Tabor Foundation   (Brazil)

Author keywords

Clinical course; Co infection; HCV genotype; Hepatitis C; HIV

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; BISEXUALITY; BRAZIL; CD4 LYMPHOCYTE COUNT; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INTRAVENOUS DRUG ABUSE; LIFE EXPECTANCY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCORING SYSTEM; SUPERINFECTION; SURVIVAL TIME;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33745067174     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702006000100004     Document Type: Article

References (25)

1. World Health Organization. Hepatitis C: Global Update. Weekly Epiderniologic Report 1997;72:341-4.
2. Thomas D.L. HCV and HIV. Conference at American Association for the Study of Liver Diseases - Postgraduate Course; 2000.
3. Wasley A, Alter M. Epidemiology of hepatitis C: geographic differences and temporal trends. Sernin Liver Dis 2000; 20: 1-16.
4. Sulkowsky M.S., Mast E.E., Sheef L.B., et al. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30:77-84.
5. Serfaty L., Chazouilleres O., Poujol-Robert A., et al. Risk factots for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology 1997;6:776-9.
6. Poynard T, Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
7. Soriano V., Garcia-Samaniego J., Rodriguez-Rosado R., et al. Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. J Hepatol 1999;31:119-23.
8. Allory Y., Charlotte E, Benhaniou Y., et al. Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: A case-control study. The Multiviric Group. Hum Pathol 2000;31:69.
9. Garcia-Samaniego J., Soriano V., Castilla J., et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group. Am J Gastroenterol 1997;92:1130-4.
10. Bierhoff E., Fischer H.P., Willsch E., et al. Liver histopathology in patients with concurrent chronic hepatits C and HIV infection. Virshows Archives 1997;430:271.
11. Bica J., McGovern B., Dhar R., et al. Increasing mortality due to end stage liver disease in patitents with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-7.
12. Sulkowski M.S., Thomas D.L., Chaisson R.E., Moore R.D. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74-80.
13. Soriano V., Garcia-Samaniego J., Valencia E., et al. Impact of chronic viral liver disease due to hepatitis viruses as cause of hospital admission and death in HIV infected drug users. Eur J Epidemiol 1999;15:1-4.
14. Di Perri G, Raiteri R., Bonora S., et al. Liver failure from HCV as the current leading cause of death in HIV-infected patients in northern Italy. In: Program and abstracts: 8th CROI 2001;573A.
15. Sulkowski M.S., Thomas D.L. Hepatitis C in the HIV infected person. Ann Intern Med 2003;138:197-207.
16. Saillour F., Dabis F., Dupon M., et al. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidemiologie Clinique du STDA en Aquitaine. Br Med J 1996;313:461-4.
17. Mohsen A.H., Trent HCV study group. The epidemiology of hepatitis C in a UK regional population of 5.12 million. Gut 2001;5:707-13.
18. Silva L., Parana R., Sousa S., et al. Hepatitis C virus genotypes in a northeastern area of Brazil. The American Journal of Tropical Medicine and Hygiene 2000;62:257-60.
19. Zeuzem S., Franke A., Lee J., et al. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viraemia, liver function tests and histology. Hepatology 1996;43:10039.
20. Pol S., Lamorthe B., Thi N.T., et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis in a large cohort of users. J Hepatol 1998;945:28.
21. Staples C.T., Jr. Rimbland D., Dudas D., et al. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 1999;29: 150-4.
22. Benhamou Y., Bochet M., Di M. Charlotte, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multiviric Group. Hepatology 1999;30:1054-8.
23. Soto B., Sanchez-Quijano A., Rodrigo L., et al. Human I immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5.
24. Darby S., Ewart D., Giagrande P, et al. Mortality from liver cancer and liver disease in hemophiliac men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350:1425-31.
25. Puoti M., Bonacini M., Spinetti A., et al. Liver fibrosis progression as related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 2001;183:134-7.